Announcements

Cancers (ISSN: 2072-6694) is an open access journal, granting readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer biomarkers in 2024, which are listed below:

1. “Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis”
by Taha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo and Deniz Can Guven
Cancers 2024, 16(21), 3689; https://doi.org/10.3390/cancers16213689
Available online: https://www.mdpi.com/2072-6694/16/21/3689

2. “Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy”
by Chloe Springer, Danish Humayun and Rachid Skouta
Cancers 2024, 16(3), 647; https://doi.org/10.3390/cancers16030647
Available online: https://www.mdpi.com/2072-6694/16/3/647

3. “Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma”
by Lena Nanz, Ulrike Keim, Alexander Katalinic, Thomas Meyer, Claus Garbe and Ulrike Leiter
Cancers 2024, 16(3), 606; https://doi.org/10.3390/cancers16030606
Available online: https://www.mdpi.com/2072-6694/16/3/606

4. “ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer”
by Aakash Desai, Tadana A. Vázquez, Keishla M. Arce, Marcelo Corassa, Philip C. Mack, Jhanelle E. Gray and Bruna Pellini
Cancers 2024, 16(5), 940; https://doi.org/10.3390/cancers16050940
Available online: https://www.mdpi.com/2072-6694/16/5/940

5. “JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature”
by Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, Bardia Danaei, Yasamin Kalantari, Patrick Fazeli, Sara Sadeghi, Nima Hajizadeh, Chalid Assaf and Ifa Etesami
Cancers 2024, 16(5), 861; https://doi.org/10.3390/cancers16050861
Available online: https://www.mdpi.com/2072-6694/16/5/861

6. “Digital Pathology for Better Clinical Practice”
by Assia Hijazi, Carlo Bifulco, Pamela Baldin and Jérôme Galon
Cancers 2024, 16(9), 1686; https://doi.org/10.3390/cancers16091686
Available online: https://www.mdpi.com/2072-6694/16/9/1686

7. “Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy”
by Song Yang, Yumeng Sun, Wei Liu, Yi Zhang, Guozhu Sun, Bai Xiang and Jiankai Yang
Cancers 2024, 16(4), 823; https://doi.org/10.3390/cancers16040823
Available online: https://www.mdpi.com/2072-6694/16/4/823

8. “Artificial Intelligence in Head and Neck Cancer Diagnosis: A Comprehensive Review with Emphasis on Radiomics, Histopathological, and Molecular Applications”
by Giuseppe Broggi, Antonino Maniaci, Mario Lentini, Andrea Palicelli, Magda Zanelli, Maurizio Zizzo, Nektarios Koufopoulos, Serena Salzano, Manuel Mazzucchelli and Rosario Caltabiano
Cancers 2024, 16(21), 3623; https://doi.org/10.3390/cancers16213623
Available online: https://www.mdpi.com/2072-6694/16/21/3623

9. “Advances in Personalized Oncology”
by Hiba Mechahougui, James Gutmans, Gina Colarusso, Roumaïssa Gouasmi and Alex Friedlaender
Cancers 2024, 16(16), 2862; https://doi.org/10.3390/cancers16162862
Available online: https://www.mdpi.com/2072-6694/16/16/2862

10. “Supplement Use and Increased Risks of Cancer: Unveiling the Other Side of the Coin”
by Parnian Jabbari, Omid Yazdanpanah, David J. Benjamin and Arash Rezazadeh Kalebasty
Cancers 2024, 16(5), 880; https://doi.org/10.3390/cancers16050880
Available online: https://www.mdpi.com/2072-6694/16/5/880

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to “Transplant Oncology” in 2024, which are listed below:

1. “Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study”
by Alex Juárez, María Queralt Salas, Alexandra Pedraza, María Suárez-Lledó, Luís Gerardo Rodríguez-Lobato, María Teresa Solano, Anna Serrahima, Meritxell Nomdedeu, Joan Cid, Miquel Lozano et al.
Cancers 2024, 16(14), 2567; https://doi.org/10.3390/cancers16142567
Available online: https://www.mdpi.com/2072-6694/16/14/2567

2. “Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial”
by Vera Himmelsbach, Matthias Jeschke, Christian M. Lange, Bernhard Scheiner, Matthias Pinter, Friedrich Sinner, Marino Venerito, Alexander Queck, Jörg Trojan, Oliver Waidmann et al.
Cancers 2024, 16(13), 2442; https://doi.org/10.3390/cancers16132442
Available online: https://www.mdpi.com/2072-6694/16/13/2442

3. “Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors”
by Nicola De Stefano, Damiano Patrono, Fabio Colli, Giorgia Rizza, Gianluca Paraluppi and Renato Romagnoli
Cancers 2024, 16(13), 2374; https://doi.org/10.3390/cancers16132374
Available online: https://www.mdpi.com/2072-6694/16/13/2374

4. “Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group”
by Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Magdalena Topczewska, Martyna Maciejewska, Magdalena Dutka, Jan Maciej Zaucha, Anna Szmigielska-Kapłon, Mateusz Nowicki, Magdalena Olszewska-Szopa, Agnieszka Szeremet et al.
Cancers 2024, 16(14), 2588; https://doi.org/10.3390/cancers16142588
Available online: https://www.mdpi.com/2072-6694/16/14/2588

5. “Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies”
by Ezequiel Mauro, Marco Sanduzzi-Zamparelli, Gabrielle Jutras, Raquel Garcia, Alexandre Soler Perromat, Neus Llarch, Victor Holguin Arce, Pablo Ruiz, Jordi Rimola, Eva Lopez et al.
Cancers 2024, 16(17), 3059; https://doi.org/10.3390/cancers16173059
Available online: https://www.mdpi.com/2072-6694/16/17/3059

6. “Cine-MRI and T1TSE Sequence for Mediastinal Mass”
by Matthias Grott, Nabil Khan, Martin E. Eichhorn, Claus Peter Heussel, Hauke Winter, Neus Llarch, and Monika Eichinger
Cancers 2024, 16(18), 3162; https://doi.org/10.3390/cancers16183162
Available online: https://www.mdpi.com/2072-6694/16/18/3162

7. “Evaluation of Subclinical Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Hematopoietic Stem Cell Transplantation: An Echocardiography Study”
by Audrone Vaitiekiene, Migle Kulboke, Monika Bieseviciene, Austeja Kaunaite, Auste Markeviciute, Agne Bartnykaite, Benas Kireilis, Diana Rinkuniene, Antanas Jankauskas, Ignas Gaidamavicius et al.
Cancers 2024, 16(22), 3808; https://doi.org/10.3390/cancers16223808
Available online: https://www.mdpi.com/2072-6694/16/22/3808

8. “Evolution of Nutritional Status in Patients Undergoing Autologous and Allogeneic Hematopoietic Cell Transplantation or CAR-T Therapy: A Retrospective Observational Study”
by Roberto Regazzoni, Sergio Ferrante, Emanuela Morenghi, Diego Lopane, Manuela Pastore, Daniela Cattani, Simone Cosmai, Francesco Colotta, Elena Azzolini, Marco Sguanci et al.
Cancers 2025, 17(1), 79; https://doi.org/10.3390/cancers17010079
Available online: https://www.mdpi.com/2072-6694/17/1/79

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer survivorship and quality of life in 2024, which are listed below:

1. “Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model”
by Kimberley T. Lee, Hailey W. Bulls, Aasha I. Hoogland, Brian W. James, Claudia B. Colon-Echevarria and Heather S. L. Jim
Cancers 2024, 16(14), 2571; https://doi.org/10.3390/cancers16142571
Available online: https://www.mdpi.com/2072-6694/16/14/2571

2. “Prevention of Anthracyclines and HER2 Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis”
by Ioanna Myrto Sotiropoulou, Nikolaos Manetas-Stavrakakis, Christos Kourek, Andrew Xanthopoulos, Dimitrios Magouliotis, Grigorios Giamouzis, John Skoularigis and Alexandros Briasoulis
Cancers 2024, 16(13), 2419; https://doi.org/10.3390/cancers16132419
Available online: https://www.mdpi.com/2072-6694/16/13/2419

3. “The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects”
by Walid Shalata, Omar Abu Saleh, Lena Tourkey, Sondos Shalata, Ala Eddin Neime, Ali Abu Juma’a, Arina Soklakova, Lama Tourkey, Ashraf Abu Jama and Alexander Yakobson
Cancers 2024, 16(16), 2909; https://doi.org/10.3390/cancers16162909
Available online: https://www.mdpi.com/2072-6694/16/16/2909

4. “Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B”
by Ploutarchos Pastras, Evaggelos Zazas, Maria Kalafateli, Ioanna Aggeletopoulou, Efthymios P. Tsounis, Stavros Kanaloupitis, Konstantinos Zisimopoulos, Eirini-Eleni-Konstantina Kottaridou, Aspasia Antonopoulou, Dimosthenis Drakopoulos et al.
Cancers 2024, 16(14), 2521; https://doi.org/10.3390/cancers16142521
Available online: https://www.mdpi.com/2072-6694/16/14/2521

5. “Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway and Sweden”
by Kari Hemminki, Frantisek Zitricky, Asta Försti, Tuija Tapaninen, Akseli Hemminki, Gunnar Juliusson and Carsten Utoft Niemann
Cancers 2024, 16(18), 3229; https://doi.org/10.3390/cancers16183229
Available online: https://www.mdpi.com/2072-6694/16/18/3229

6. “Mediating Effects of Self-Efficacy and Illness Perceptions on Mental Health in Men with Localized Prostate Cancer: A Secondary Analysis of the Prostate Cancer Patient Empowerment Program (PC-PEP) Randomized Controlled Trial”
by Cody MacDonald, Gabriela Ilie, George Kephart, Ricardo Rendon, Ross Mason, Greg Bailly, David Bell, Nikhilesh Patil, David Bowes, Derek Wilke et al.
Cancers 2024, 16(13), 2352; https://doi.org/10.3390/cancers16132352
Available online: https://www.mdpi.com/2072-6694/16/13/2352

7. “Limited Evidence for the Benefits of Exercise in Older Adults with Hematological Malignancies: A Systematic Review and Meta-Analysis”
by Mary Jarden, Sofie Tscherning Lindholm, Gudrun Kaldan, Charlotte Grønset, Rikke Faebo Larsen, Anders Thyge Steen Larsen, Mette Schaufuss Engedal, Marta Kramer Mikkelsen, Dorte Nielsen, Anders Vinther et al.
Cancers 2024, 16(17), 2962; https://doi.org/10.3390/cancers16172962
Available online: https://www.mdpi.com/2072-6694/16/17/2962

8. “The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma”
by Matteo Boltri, Fabio Traunero, Luca Ongaro, Francesca Migliozzi, Fabio Vianello, Oliviero Lenardon, Francesco Visalli, Lorenzo Buttazzi, Daniele Maruzzi, Carlo Trombetta et al.
Cancers 2024, 16(20), 3519; https://doi.org/10.3390/cancers16203519
Available online: https://www.mdpi.com/2072-6694/16/20/3519

9. “The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity”
by Razvan Constantin Vonica, Anca Butuca, Andreea Loredana Vonica-Tincu, Claudiu Morgovan, Manuela Pumnea, Remus Calin Cipaian, Razvan Ovidiu Curca, Florina Batar, Vlad Vornicu, Adelaida Solomon et al.
Cancers 2024, 16(22), 3847; https://doi.org/10.3390/cancers16223847
Available online: https://www.mdpi.com/2072-6694/16/22/3847

10. “Stratification of Homologous Recombination Deficiency-Negative High-Grade Ovarian Cancer by the Type of Peritoneal Spread into Two Groups with Distinct Survival Outcomes”
by Simon Schnaiter, Esther Schamschula, Juliane Laschtowiczka, Heidelinde Fiegl, Johannes Zschocke, Alain Zeimet, Katharina Wimmer and Daniel Reimer
Cancers 2024, 16(11), 2129; https://doi.org/10.3390/cancers16112129
Available online: https://www.mdpi.com/2072-6694/16/11/2129

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to methods and technologies development in 2024, which are listed below:

1. “Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches”
by Marie-France Bellin, Catarina Valente, Omar Bekdache, Florian Maxwell, Cristina Balasa, Alexia Savignac and Olivier Meyrignac
Cancers 2024, 16(10), 1926; https://doi.org/10.3390/cancers16101926
Available online: https://www.mdpi.com/2072-6694/16/10/1926

2. “A Hybrid Deep Learning and Machine Learning Approach with Mobile-EfficientNet and Grey Wolf Optimizer for Lung and Colon Cancer Histopathology Classification”
by Raquel Ochoa-Ornelas, Alberto Gudiño-Ochoa and Julio Alberto García-Rodríguez
Cancers 2024, 16(22), 3791; https://doi.org/10.3390/cancers16223791
Available online: https://www.mdpi.com/2072-6694/16/22/3791

3. “Photodynamic Therapy and Adaptive Immunity Induced by Reactive Oxygen Species: Recent Reports”
by David Aebisher, Paweł Woźnicki and Dorota Bartusik-Aebisher
Cancers 2024, 16(5), 967; https://doi.org/10.3390/cancers16050967
Available online: https://www.mdpi.com/2072-6694/16/5/967

4. “Assessing Trifecta and Pentafecta Success Rates between Robot-Assisted vs. Open Radical Cystectomy: A Propensity Score-Matched Analysis”
by Filippo Gavi, Nazario Foschi, Daniele Fettucciari, Pierluigi Russo, Diana Giannarelli, Mauro Ragonese, Carlo Gandi, Giovanni Balocchi, Alessandra Francocci, Francesco Pio Bizzarri et al.
Cancers 2024, 16(7), 1270; https://doi.org/10.3390/cancers16071270
Available online: https://www.mdpi.com/2072-6694/16/7/1270

5. “Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence”
by Ashwin Mukund, Muhammad Ali Afridi, Aleksandra Karolak, Margaret A. Park, Jennifer B. Permuth and Ghulam Rasool
Cancers 2024, 16(12), 2240; https://doi.org/10.3390/cancers16122240
Available online: https://www.mdpi.com/2072-6694/16/12/2240

6. “Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma”
by Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio and Hie-Won Hann
Cancers 2024, 16(4), 777; https://doi.org/10.3390/cancers16040777
Available online: https://www.mdpi.com/2072-6694/16/4/777

7. “Grad-CAM Enabled Breast Cancer Classification with a 3D Inception-ResNet V2: Empowering Radiologists with Explainable Insights”
by Fatma M. Talaat, Samah A. Gamel, Rana Mohamed El-Balka, Mohamed Shehata and Hanaa ZainEldin
Cancers 2024, 16(21), 3668; https://doi.org/10.3390/cancers16213668
Available online: https://www.mdpi.com/2072-6694/16/21/3668

8. “Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma”
by Fereshteh Yousefirizi, Claire Gowdy, Ivan S. Klyuzhin, Maziar Sabouri, Petter Tonseth, Anna R. Hayden, Donald Wilson, Laurie H. Sehn, David W. Scott, Christian Steidl et al.
Cancers 2024, 16(6), 1090; https://doi.org/10.3390/cancers16061090
Available online: https://www.mdpi.com/2072-6694/16/6/1090

9. “Performance of Commercial Dermatoscopic Systems That Incorporate Artificial Intelligence for the Identification of Melanoma in General Practice: A Systematic Review”
by Ian Miller, Nedeljka Rosic, Michael Stapelberg, Jeremy Hudson, Paul Coxon, James Furness, Joe Walsh and Mike Climstein
Cancers 2024, 16(7), 1443; https://doi.org/10.3390/cancers16071443
Available online: https://www.mdpi.com/2072-6694/16/7/1443

10. “Single-Port Extraperitoneal vs. Multiport Transperitoneal Robot-Assisted Radical Prostatectomy: A Propensity Score-Matched Analysis”
by Jaya S. Chavali, Adriana M. Pedraza, Nicolas A. Soputro, Roxana Ramos-Carpinteyro, Carter D. Mikesell and Jihad Kaouk
Cancers 2024, 16(17), 2994; https://doi.org/10.3390/cancers16172994
Available online: https://www.mdpi.com/2072-6694/16/17/2994

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer informatics and big data in 2024, which are listed below:

1. “Predictive and Prognostic Relevance of Tumor-Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types”
by Tikam Chand Dakal, Nancy George, Caiming Xu, Prashanth Suravajhala and Abhishek Kumar
Cancers 2024, 16(9), 1626; https://doi.org/10.3390/cancers16091626
Available online: https://www.mdpi.com/2072-6694/16/9/1626

2. “NDRGs in Breast Cancer: A Review and In Silico Analysis”
by Emilly S. Villodre, Anh P. N. Nguyen and Bisrat G. Debeb
Cancers 2024, 16(7), 1342; https://doi.org/10.3390/cancers16071342
Available online: https://www.mdpi.com/2072-6694/16/7/1342

3. “PathoGraph: An Attention-Based Graph Neural Network Capable of Prognostication Based on CD276 Labelling of Malignant Glioma Cells”
by Islam Alzoubi, Lin Zhang, Yuqi Zheng, Christina Loh, Xiuying Wang and Manuel B. Graeber
Cancers 2024, 16(4), 750; https://doi.org/10.3390/cancers16040750
Available online: https://www.mdpi.com/2072-6694/16/4/750

4. “Identification of Interpretable Clusters and Associated Signatures in Breast Cancer Single-Cell Data: A Topic Modeling Approach”
by Gabriele Malagoli, Filippo Valle, Emmanuel Barillot, Michele Caselle and Loredana Martignetti
Cancers 2024, 16(7), 1350; https://doi.org/10.3390/cancers16071350
Available online: https://www.mdpi.com/2072-6694/16/7/1350

5. “Single-Cell Profiling Reveals the Impact of Genetic Alterations on the Differentiation of Inflammation-Induced Murine Colon Tumors”
by Ahmed H. Ghobashi, Rosie Lanzloth, Christopher A. Ladaika, Ashiq Masood and Heather M. O’Hagan
Cancers 2024, 16(11), 2040; https://doi.org/10.3390/cancers16112040
Available online: https://www.mdpi.com/2072-6694/16/11/2040

6. “Enhancing Cancerous Gene Selection and Classification for High-Dimensional Microarray Data Using a Novel Hybrid Filter and Differential Evolutionary Feature Selection”
by Arshad Hashmi, Waleed Ali, Anas Abulfaraj, Faisal Binzagr and Entisar Alkayal
Cancers 2024, 16(23), 3913; https://doi.org/10.3390/cancers16233913
Available online: https://www.mdpi.com/2072-6694/16/23/3913

7. “Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks”
by Joaquim Carreras, Giovanna Roncador and Rifat Hamoudi
Cancers 2024, 16(24), 4230; https://doi.org/10.3390/cancers16244230
Available online: https://www.mdpi.com/2072-6694/16/24/4230

8. “Is the Validity of Logistic Regression Models Developed with a National Hospital Database Inferior to Models Developed from Clinical Databases to Analyze Surgical Lung Cancers?”
by Alain Bernard, Jonathan Cottenet and Catherine Quantin
Cancers 2024, 16(4), 734; https://doi.org/10.3390/cancers16040734
Available online: https://www.mdpi.com/2072-6694/16/4/734

9. “Deep Learning for Melanoma Detection: A Deep Learning Approach to Differentiating Malignant Melanoma from Benign Melanocytic Nevi”
by Magdalini Kreouzi, Nikolaos Theodorakis, Georgios Feretzakis, Evgenia Paxinou, Aikaterini Sakagianni, Dimitris Kalles, Athanasios Anastasiou, Vassilios S. Verykios and Maria Nikolaou
Cancers 2025, 17(1), 28; https://doi.org/10.3390/cancers17010028
Available online: https://www.mdpi.com/2072-6694/17/1/28

10. “Robustness Assessment of Oncology Dose-Finding Trials Using the Modified Fragility Index”
by Amy X. Shi, Heng Zhou, Lei Nie, Lifeng Lin, Hongjian Li and Haitao Chu
Cancers 2024, 16(20), 3504; https://doi.org/10.3390/cancers16203504
Available online: https://www.mdpi.com/2072-6694/16/20/3504

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

In September, the WHO-recognized Childhood Cancer Awareness Month features global activities to raise awareness and support for childhood cancer research. We would like to take this opportunity to extend our appreciation to all of the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of childhood cancer that have been published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for all individuals interested in this field.

“Association of Insulin-like Growth Factor-1 with Bone Mineral Density in Survivors of Childhood Acute Leukemia”
by Seulki Kim, Jae Won Yoo, Jae Wook Lee, Min Ho Jung, Bin Cho, Byng-Kyu Suh, Moon Bae Ahn and Nack-Gyun Chung
Cancers 2024, 16(7), 1296; https://doi.org/10.3390/cancers16071296

“Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia”
by Jiasen He, Faryal Munir, Samanta Catueno, Jeremy S. Connors, Amber Gibson, Lindsay Robusto, David McCall, Cesar Nunez, Michael Roth, Priti Tewari et al.
Cancers 2024, 16(5), 858; https://doi.org/10.3390/cancers16050858

“Causes of Childhood Cancer: A Review of the Recent Literature: Part I—Childhood Factors”
by Angela M. Ricci, Rebecca T. Emeny, Pamela J. Bagley, Heather B. Blunt, Mary E. Butow, Alexandra Morgan, Jennifer A. Alford-Teaster, Linda Titus, Raymond R. Walston, III and Judy R. Rees
Cancers 2024, 16(7), 1297; https://doi.org/10.3390/cancers16071297

“Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990–2017, with Emphasis on Indigenous Peoples”
by Suzanne Mashtoub, Shahid Ullah, Anne Collinson, Gurmeet R. Singh, Justine Clark (Adnyamathanha), Shalem Leemaqz, Ora Paltiel, David M. Roder, Benjamin Saxon, Ross McKinnon et al.
Cancers 2024, 16(11), 2057; https://doi.org/10.3390/cancers16112057

“Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances”
by Adrian Kowalczyk, Julia Zarychta, Anna Marszołek, Joanna Zawitkowska and Monika Lejman
Cancers 2024, 16(3), 623; https://doi.org/10.3390/cancers16030623

“Extracellular Vesicles for Childhood Cancer Liquid Biopsy”
by Nilubon Singhto, Pongpak Pongphitcha, Natini Jinawath, Suradej Hongeng and Somchai Chutipongtanate
Cancers 2024, 16(9), 1681; https://doi.org/10.3390/cancers16091681

“Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges”
by Anup Singh Pathania
Cancers 2024, 16(12), 2201; https://doi.org/10.3390/cancers16122201

“Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges”
by Manuela Mandorino, Ahana Maitra, Domenico Armenise, Olga Maria Baldelli, Morena Miciaccia, Savina Ferorelli, Maria Grazia Perrone and Antonio Scilimati
Cancers 2024, 16(10), 1814; https://doi.org/10.3390/cancers16101814

“Therapeutic Parent–Child Communication and Health Outcomes in the Childhood Cancer Context: A Scoping Review”
by Heeyeon Son and Nani Kim
Cancers 2024, 16(11), 2152; https://doi.org/10.3390/cancers16112152

“Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective”
by Hiroshi Hayashi, Atsushi Makimoto and Yuki Yuza
Cancers 2024, 16(4), 723; https://doi.org/10.3390/cancers16040723

“New Advances in the Treatment of Pediatric Solid Tumors” Guest Editors: Prof. Dr. Myriam Weyl Ben-Arush and Dr. Oz Mordechai Submission deadline: 20 November 2025	“Pediatric Cancer Research from Basic Biology to Experimental Therapy” Guest Editor: Prof. Dr. Atif Ahmed Submission deadline: 16 January 2026

“Pediatric Cancers” Edited by Saurabh Agarwal and Jianhua Yang https://doi.org/10.3390/books978-3-0365-9025-7 This is a Reprint of the Special Issue “Pediatric Cancers” that was published in Cancers.

MDPI will attend ASN Kidney Week 2025, which will take place from 6 to 9 November 2025, at the George R. Brown Convention Center, in Houston, USA.

The American Society of Nephrology (ASN) invites you to participate in the largest and most influential international gathering of kidney professionals worldwide. Join the kidney community as we come together with a shared focus on improving the lives of over 850 million people across the globe. At Kidney Week 2025 in Houston, TX, you will have the opportunity to engage with more than 12,000 kidney professionals and experience the Scientific Exposition, which showcases the latest advances in treatment, research, and cutting-edge technology in nephrology. As the world’s premier nephrology meeting, Kidney Week offers exciting and challenging opportunities to exchange knowledge, discover the newest scientific and medical developments, and take part in engaging discussions with leading experts in the field.

MDPI is excited to participate in this prestigious event. We welcome you to visit MDPI’s booth, where you will be able to have face-to-face exchanges with our representatives, and learn more about our open access publishing services.

The following MDPI journals will be represented:

• Kidney and Dialysis;
• Applied Biosciences;
• Biomedicines;
• Cancers;
• Cells;
• Children;
• Clinics and Practice;
• Diabetology;
• Diseases;
• Genes;
• Healthcare;
• IJERPH;
• IJTM;
• Immuno;
• J;
• JMP;
• JPM;
• Life;
• Medical Sciences;
• Metabolites;
• Sci. Pharm.;
• Therapeutics;
• Transplantology;
• Vaccines.

If you plan to attend this event, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have. For more information about the conference, please visit the official website: https://www.asn-online.org/kidneyweek.

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer epidemiology and prevention in 2024, which are listed below:

1. “Distribution during the COVID-19 Pandemic in Patients with Head and Neck Squamous Cell Carcinoma at a Large Hungarian Cancer Center”
by Éva Szabó, Eszter Kopjár, László Rumi, Árpád Boronkai, Szabolcs Bellyei, Zoltán Gyöngyi, Antal Zemplényi, Balázs Sütő, János Girán, István Kiss et al.
Cancers 2024, 16(14), 2570; https://doi.org/10.3390/cancers16142570
Available online: https://www.mdpi.com/2072-6694/16/14/2570

2. “Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment”
by Adam Barsouk, Omar Elghawy, Austin Yang, Jonathan H. Sussman, Ronac Mamtani and Lin Mei
Cancers 2024, 16(19), 3228; https://doi.org/10.3390/cancers16193338
Available online: https://www.mdpi.com/2072-6694/16/19/3338

3. “Impact of Age, Period, Cohort, Region, Race, and Health Services on Bladder Cancer Mortality in Brazil: A 23-Year Ecological Study”
by João Simão de Melo Neto, Sâmia Feitosa Miguez, Amanda Lia Rebelo Rabel, Amanda Marinho da Silva, Daniel Souza Sacramento, Dária Barroso Serrão das Neves, Iana Nogueira Rego, Riter Lucas Miranda Garcia, Deizyane dos Reis Galhardo and André Luiz Machado das Neves
Cancers 2024, 16(17), 3028; https://doi.org/10.3390/cancers16173038
Available online: https://www.mdpi.com/2072-6694/16/17/3038

4. “Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting”
by Stefanie Ho Yi Chan, Deborah Layton, Sherael Webley and Sam Salek
Cancers 2024, 16(24), 4223; https://doi.org/10.3390/cancers16244223
Available online: https://www.mdpi.com/2072-6694/16/24/4223

5. “Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis”
by Agnieszka Drab, Krystian Wdowiak, Wiesław Kanadys, Krzysztof Zajączkowski, Paweł Koczkodaj, Urszula Religioni, Mariola Borowska, Magdalena Łoś and Macarena Lozano-Lorca
Cancers 2024, 16(23), 4010; https://doi.org/10.3390/cancers16234010
Available online: https://www.mdpi.com/2072-6694/16/23/4010

6. “Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective”
by Rahul Ladwa, Gerald Fogarty, Peggy Chen, Gurpreet Grewal, Chris McCormack, Victoria Mar, Delphine Kerob and Kiarash Khosrotehrani
Cancers 2024, 16(14), 2526; https://doi.org/10.3390/cancers16142526
Available online: https://www.mdpi.com/2072-6694/16/14/2526

7. “Comparative Analysis of AML Classification Systems: Evaluating the WHO, ICC, and ELN Frameworks and Their Distinctions”
by Huda Salman
Cancers 2024, 16(16), 2915; https://doi.org/10.3390/cancers16162915
Available online: https://www.mdpi.com/2072-6694/16/16/2915

8. “Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study”
by Linda Titus, Elizabeth E. Hatch, Kimberly A. Bertrand, Julie R. Palmer, William C. Strohsnitter, Dezheng Huo, Michael Curry, Marianne Hyer, Kjersti Aagaard, Gretchen L. Gierach et al.
Cancers 2024, 16(14), 2575; https://doi.org/10.3390/cancers16142575
Available online: https://www.mdpi.com/2072-6694/16/14/2575

9. “Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes”
by Paraskevi Apostolou, Vasiliki Dellatola, Athanasios Papathanasiou, Despoina Kalfakakou, Elena Fountzilas, Dimitrios Tryfonopoulos, Sofia Karageorgopoulou, Drakoulis Yannoukakos, Irene Konstantopoulou and Florentia Fostira
Cancers 2024, 16(13), 2368; https://doi.org/10.3390/cancers16132368
Available online: https://www.mdpi.com/2072-6694/16/13/2368

10. “Gastric Epithelial Polyps: Current Diagnosis, Management, and Endoscopic Frontiers”
by Diego Reyes-Placencia, Elisa Cantú-Germano, Gonzalo Latorre, Alberto Espino, Glòria Fernández-Esparrach and Leticia Moreira
Cancers 2024, 16(22), 3771; https://doi.org/10.3390/cancers16223771
Available online: https://www.mdpi.com/2072-6694/16/22/3771

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of blood cancer, which are listed below:

“Venetoclax Resistance in Acute Myeloid Leukemia”
by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette and Norbert Vey
Cancers 2024, 16(6), 1091; https://doi.org/10.3390/cancers16061091
Available online: https://www.mdpi.com/2072-6694/16/6/1091

“Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective”
by Hiroshi Hayashi, Atsushi Makimoto and Yuki Yuza
Cancers 2024, 16(4), 723; https://doi.org/10.3390/cancers16040723
Available online: https://www.mdpi.com/2072-6694/16/4/723

“JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature”
by Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, Bardia Danaei, Yasamin Kalantari, Patrick Fazeli, Sara Sadeghi, Nima Hajizadeh, Chalid Assaf and Ifa Etesami
Cancers 2024, 16(5), 861; https://doi.org/10.3390/cancers16050861
Available online: https://www.mdpi.com/2072-6694/16/5/861

“Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma”
by Fereshteh Yousefirizi, Claire Gowdy, Ivan S. Klyuzhin, Maziar Sabouri, Petter Tonseth, Anna R. Hayden, Donald Wilson, Laurie H. Sehn, David W. Scott, Christian Steidl et al.
Cancers 2024, 16(6), 1090; https://doi.org/10.3390/cancers16061090
Available online: https://www.mdpi.com/2072-6694/16/6/1090

“Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment”
by Fauzia Ullah, Mariam Markouli, Mark Orland, Olisaemeka Ogbue, Danai Dima, Najiullah Omar and Moaath K. Mustafa Ali
Cancers 2024, 16(7), 1307; https://doi.org/10.3390/cancers16071307
Available online: https://www.mdpi.com/2072-6694/16/7/1307

“Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients”
by Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali et al.
Cancers 2024, 16(15), 2764; https://doi.org/10.3390/cancers16152764
Available online: https://www.mdpi.com/2072-6694/16/15/2764

“Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas”
by Francesco D’Alò, Silvia Bellesi, Elena Maiolo, Eleonora Alma, Flaminia Bellisario, Rosalia Malafronte, Marcello Viscovo, Fabrizia Campana and Stefan Hohaus
Cancers 2024, 16(12), 2243; https://doi.org/10.3390/cancers16122243
Available online: https://www.mdpi.com/2072-6694/16/12/2243

“Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations”
by Philipp Blüm and Sabine Kayser
Cancers 2024, 16(8), 1599; https://doi.org/10.3390/cancers16081599
Available online: https://www.mdpi.com/2072-6694/16/8/1599

“Enhancing Lymphoma Diagnosis, Treatment, and Follow-Up Using ¹⁸F-FDG PET/CT Imaging: Contribution of Artificial Intelligence and Radiomics Analysis”
by Setareh Hasanabadi, Seyed Mahmud Reza Aghamiri, Ahmad Ali Abin, Hamid Abdollahi, Hossein Arabi and Habib Zaidi
Cancers 2024, 16(20), 3511; https://doi.org/10.3390/cancers16203511
Available online: https://www.mdpi.com/2072-6694/16/20/3511

“T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies”
by Paweł Cech, Katarzyna Skórka, Laura Dziki and Krzysztof Giannopoulos
Cancers 2024, 16(8), 1580; https://doi.org/10.3390/cancers16081580
Available online: https://www.mdpi.com/2072-6694/16/8/1580

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer immunology and immunotherapy in 2024, which are listed below:

1. “Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations”
by Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti and Antonello Veccia
Cancers 2024, 16(7), 1440; https://doi.org/10.3390/cancers16071440
Available online: https://www.mdpi.com/2072-6694/16/7/1440

2. “Syngeneic Mouse Models for Pre-Clinical Evaluation of CAR T Cells”
by Eman N. Ahmed, Lauren C. Cutmore and John F. Marshall
Cancers 2024, 16(18), 3186; https://doi.org/10.3390/cancers16183186
Available online: https://www.mdpi.com/2072-6694/16/18/3186

3. “T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies”
by Paweł Cech, Katarzyna Skórka, Laura Dziki and Krzysztof Giannopoulos
Cancers 2024, 16(8), 1580; https://doi.org/10.3390/cancers16081580
Available online: https://www.mdpi.com/2072-6694/16/8/1580

4. “Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting”
by Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli and Giuseppe Curigliano
Cancers 2024, 16(2), 281; https://doi.org/10.3390/cancers16020281
Available online: https://www.mdpi.com/2072-6694/16/2/281

5. “Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer”
by Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J. Raftery and Gabriele Pecher
Cancers 2024, 16(2), 388; https://doi.org/10.3390/cancers16020388
Available online: https://www.mdpi.com/2072-6694/16/2/388

6. “MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC)”
by Qiulin Wu, Xicai Li, Yan Yang, Jingquan Huang, Ming Yao, Jianjun Li, Yubin Huang, Xiaoyong Cai, David A. Geller and Yihe Yan
Cancers 2024, 16(2), 269; https://doi.org/10.3390/cancers16020269
Available online: https://www.mdpi.com/2072-6694/16/2/269

7. “Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer”
by Ramya Ayyalasomayajula and Mare Cudic
Cancers 2024, 16(7), 1334; https://doi.org/10.3390/cancers16071334
Available online: https://www.mdpi.com/2072-6694/16/7/1334

8. “Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors”
by Masahiko Sue, Yasuto Takeuchi, Shoichiro Hirata, Akinobu Takaki and Motoyuki Otsuka
Cancers 2024, 16(10), 1811; https://doi.org/10.3390/cancers16101811
Available online: https://www.mdpi.com/2072-6694/16/10/1811

9. “Checkpoint Inhibitors in Dogs: Are We There Yet?”
by Antonio Giuliano, Pedro A. B. Pimentel and Rodrigo S. Horta
Cancers 2024, 16(11), 2003; https://doi.org/10.3390/cancers16112003
Available online: https://www.mdpi.com/2072-6694/16/11/2003

10. “The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications”
by Adam Merenstein, Loiy Obeidat, Apostolos Zaravinos and Benjamin Bonavida
Cancers 2024, 17(1), 19; https://doi.org/10.3390/cancers17010019
Available online: https://www.mdpi.com/2072-6694/17/1/19

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office